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Background: Renal sympathetic denervation has recently gained clinical relevance for the treatment of
therapy-resistant hypertension. Denervation is currently mainly performed using catheter-based transarterial
radiofrequency ablation of periarterial sympathetic nerve fibers. Since this approach has numerous limitations, we
conducted a study to evaluate the feasibility, safety, and efficacy of magnetic resonance-guided high-focused
ultrasound (MRgHiFUS) for renal sympathetic denervation in pigs as an alternative to catheter-based ablation.
Methods: Renal periarterial MRgHiFUS was performed under general anesthesia in ten pigs. Blood pressure
measurements and magnetic resonance imaging (MRI) of the kidneys, renal arteries, and surrounding structures
were obtained immediately before and after the interventions and after 4 weeks. Histological examinations of
periarterial tissues and determination of renal norepinephrine (NE) concentration were performed to assess
treatment efficacy.
Results and discussion: In each pig, 9.8 ± 2.6 sonications with a mean energy deposition of 2,670 ± 486 J were
performed. The procedure was well tolerated by all pigs. No major complications occurred. MRgHiFUS induced
periarterial edema in three pigs, but only one pig showed corresponding histological changes. The NE level of the
treated kidney was lower in five pigs (−8% to −38%) compared to the untreated side. Overall, there was no
significant difference between the NE values of both kidneys in any of the treated pigs. Postinterventional MRI
indicated absorption of ultrasound energy at the transverse process and fascia.
Conclusion: MRgHiFUS had some thermal periarterial effects but failed to induce renal denervation. Insufficient
energy deposition is most likely attributable to a small acoustic window with beam path impediment in the
porcine model. Since HiFUS treatment in humans is expected to be easier to perform due to better access to renal
sympathetic nerves, further studies of this method are desirable to investigate the potential of MRgHiFUS as an
alternative for patients not suitable for catheter-based renal sympathicolysis.
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Hypertension is a major health burden and is on the rise,
especially in industrialized countries. About half of the
patients diagnosed with hypertension in the USA and
10% worldwide suffer from resistant hypertension, de-
fined as a persistent elevation of blood pressure (BP)
despite treatment at target dose with a combination of
at least three antihypertensive drugs from complemen-
tary classes including a diuretic [1-3].
Renal sympathetic efferent and afferent nerves play an
important role in the initiation and maintenance of re-
sistant hypertension. Elimination of these nerve fibers by
surgical resection of the splanchnic renal innervation
was already introduced as a treatment for hypertension
in the 1930s [4]. However, due to a high incidence of
complications, the surgical method was abandoned in
favor of medical treatment, which became increasingly
available and effective.
With the technical advances of recent years, denervation
of renal sympathetic nerve fibers using an intravascular ra-
diofrequency ablation (RFA) catheter has become a prom-
ising method for lowering blood pressure in patients with
refractory essential hypertension [5,6].
The results of the HTN-1 and HTN-2 trials [5,7] have
spawned the development of multiple RFA systems in-
cluding multielectrode RFA catheters and balloon-
mounted RFA catheters with or without irrigation.
Though, there exist drawbacks of catheter-based invasive
ablation, e.g., not all patients are suitable for the
catheter-based approach, as the renal arteries must have
a certain diameter and length for catheter insertion [8].
The method is invasive and may cause complications re-
lated to arterial access and intravascular advancement of
the RFA catheter. Furthermore, long-term data on pos-
sible RFA-related vascular wall injury as seen in a pre-
clinical model [9] or hemodynamically relevant renal
artery stenosis [10] are still lacking.
Apart from procedural aspects, clinical outcomes of
treated patients are very variable. Finally, the latest results
from the HTN-3 trial do not show a significant reduction
of systolic blood pressure in patients with therapy-resistant
hypertension 6 months after RFA-based renal artery de-
nervation compared with a sham control [1]. Therefore, it
is justified and necessary to investigate other potential
methods for renal sympathetic denervation.
High-focused ultrasound (HiFUS) is a noninvasive
method for tissue ablation that destroys tissue by directing
a high-power ultrasound beam on a small focus. Within
the focal volume, the resulting increase in temperature of
up to 60°C–90°C leads to soft tissue damage sparing the
surrounding tissue with a small boundary between dam-
aged and spared tissue less than ten cells wide [11]. Mag-
netic resonance imaging (MRI) with its high intrinsic soft
tissue contrast is ideal for visualizing the target structuresand planning the procedure. At present, MRI-guided
HiFUS (MRgHiFUS) is approved for the treatment of
uterine fibroids and painful bone metastases in Europe
and the USA. Experimental applications of HiFUS are cur-
rently investigated in numerous ongoing trials and range
from the treatment of different tumor entities and occlu-
sion of bleeding vessels to the ablation of arrhythmogenic
cardiac tissue or enhancement of gene therapy and tar-
geted drug delivery [12-24].
The purpose of this study was to explore the feasibility,
safety, and efficacy of MRgHiFUS as a novel approach for
renal sympathetic denervation in a swine model.
Methods
Animal study
The study was approved by the local animal research
committee (Tierversuchs-Kommission des Landes Berlin
(http://www.berlin.de/lageso/gesundheit/tierversuchskom-
mission/index.html)). The domestic swine model was
chosen for the study since its renal anatomy including ar-
terial diameter and morphology is similar to that of
humans [25]. Ten normotensive domestic pigs (weight,
27.2 ± 1.8 kg at baseline and 33.2 ± 7.1 kg at 4-week
follow-up; average diameter of the renal arteries, 3.6 and
3.8 mm (l, r)) were used to examine the effect of MRgHi-
FUS therapy on the sympathetic renal nerves by assessing
norepinephrine (NE) concentration in the renal paren-
chyma and histological changes in the renal sympathetic
nerves. Ten pigs (nos. 1–10) were treated unilaterally on
the right side with the contralateral nontreated kidney
serving as control. Coincidentally, pig 7 had a congenital
solitary right kidney. Therefore, the measured NE value
was compared with the average of all NE values of the
contralateral side of the other nine pigs. Since there was
no appropriate acoustic window for the ultrasound beam
due to a prominent transverse process, pig 10 received
unilateral sham treatment on the right side (the same pro-
cedure as for regular treatment including the test sonic-
ation but not the therapeutic sonication) and therefore
served as control to the other nine animals.
MRgHiFUS procedure
Sonications were performed with a clinical MR imaging-
integrated focused ultrasound system (ExAblate 2000;
InSightec-TxSonics, Haifa, Israel).
A focused piezoelectric transducer array with a 120-mm
diameter and operating frequencies between 1.0 and
1.5 MHz generated the ultrasound field. The array was lo-
cated in the MR imaging table in a water tank (83 × 34 ×
11 cm) containing degassed water and could be controlled
electronically to modify the focal spot and the coagulated
tissue volume. The pigs were positioned supine over the fo-
cused ultrasound device and fixed. To ensure optimal air-
free acoustic coupling, a thin gel pad was placed on top of
Figure 1 Sonication planning image. The sonication area lies
within the blue-green bar, which includes the renal artery and the
surrounding periarterial tissue.
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cluded acquisition of T2-weighted (T2-w) fast spin echo
(FSE) sequences in three orthogonal planes. Posttreatment
imaging immediately after the sonication procedure and
4 weeks after the intervention consisted of fat-saturated
(fs) T2-w FSE sequences and a contrast-enhanced three-
dimensional (3D) T2-weighted (T1-w) fast gradient echo
(FGRE) MR angiography sequence (Table 1).
After image transfer to the MRgHiFUS workstation,
the target volume was defined.
In order to ensure and verify exact focusing of the ultra-
sound beam to the target region, calibration was performed
prior to treatment. For calibration, in each pig, one to five
test sonications were performed by focusing the ultrasound
beam on the ipsilateral longissimus lumborum muscle.
Once a temperature elevation was achieved at the targeted
spot, monitored with real-time proton resonance frequency
(PRF) MR thermometry, the ultrasound beam was focused
at the renal periarterial tissue.
The levels of acoustic energy were chosen in accord-
ance with the protocol established for the treatment of
uterine fibroids in our institution. The maximum acous-
tic powers applied ranged from 100 to 166 W (average
133 W).
For renal denervation, the first sonication was placed
at the ostium of the right renal artery, and the following
sonications in 5-mm overlapping intervals were around
this spot (Figure 1). Sonication spots were chosen visu-
ally to completely cover the periarterial tissue. Further
details are listed in Table 2.
Assessment of technical outcome
Technical success was assumed if the postinterventional
T2-w images showed a signal increase in the renal peri-
arterial tissue as a sign of edema, assumed to develop in
response to thermal injury.
Procedure time was defined as the interval from the
initiation of the localizing sequence to the end of the
posttreatment T2-w FSE and T1-w MR angiography se-
quences. The time required for preparing the pigs in-
cluding anesthesia and positioning on the MRgHiFUS
table was not included.Table 1 MRI protocol for MRgHiFUS for renal sympathetic de
Protocol Sequence
Preprocedural planning T2-w FSE: axial, sagittal,
TR/TE 2,700/102 ms, ETL
MRI temperature monitoring Phase imaging with the
5.7 kHz, matrix 256 × 12
Postinterventional control Fat-saturated T2-w FSE
256 × 256, NEX 1.5, SL 4
MR angiography T1-w contrast-enhanced
frequency 63.8 kHz, pixe
TR repetition time, TE echo time, ETL echo train length, FOV field of view, NEX numbAssessment of safety and efficacy
The first two pigs treated were sacrificed 2 h after the
intervention to assess immediate effects of focused ultra-
sound on vessels and perivascular tissues. The remaining
eight pigs underwent follow-up MRI at 28 days and were
euthanized in deep anesthesia immediately thereafter.
Apart from the fat-saturated T2-w FSE sequences, the scan
protocol included contrast-enhanced MR angiography and
MR urography for the identification of ureteral stenosis,
thrombosis, hydronephrosis, or other inadvertent damage
to the nearby abdominal organs.
For histological analysis after nephrectomy, a tissue
block which included the renal vessels and any associ-
ated soft tissues was dissected and immersed in 4% neu-
tral buffered formalin. The renal artery and perirenal
arterial stroma containing renal nerves were sectioned
transversely at 3–4-mm intervals. Tissue samples were
then sectioned into 5-μm slices and stained with a
hematoxylin and eosin (H&E) stain and with an Elasticanervation
coronal
20, bandwidth 15.6 kHz, FOV 36 cm, matrix 256 × 256, NEX 1.5, SL 4 mm
use of a FSGRE sequence, TR/TE 26.4/13.1 ms, flip angle 30°, bandwidth
8, FOV 36 cm, SL 3–5 mm
TR/TE 2,700/101 ms, ETL 20, bandwidth 15.6 kHz, FOV 36 cm, matrix
mm
MR angiography FGRE 3D, TR/TE 3.45/1.2 ms, SL 1 mm, imaging
l bandwidth 420, FOV 36 cm, matrix 384 × 376, flip angle 25°
er of excitations, SL slice thickness, FSGRE fast spoiled gradient-recalled echo.
Table 2 Details of the test and therapeutic sonications in pig nos. 1–9 (mean values ± standard deviation)
Test sonications Therapeutic sonications
Number of sonications Power (W) Energy (J) Duration (s) Spot length
(mm)
Spot diameter
(mm)
Number of
sonications
Power (W) Energy (J) Duration (s) Spot length
(mm)
Spot diameter
(mm)
Pig1 3 26.3 525.3 20 17 4.1 15 100.4 2,291.3 22 17 4.1
Pig 2 5 25.8 514.8 20 17 4.1 10 141.7 3,208 22.8 28.2 6.6
Pig 3 2 39 465 12 24 4.9 8 146.6 1,759.8 12 25.1 4.8
Pig 4 2 33 319 12 24 5.6 12 136.8 2,355.5 17.2 27.8 5.8
Pig 5 2 30 599.5 20 26 6.4 7 165.6 3,309.3 20 28.9 7.2
Pig 6 1 27 542 20 26 6.4 7 141.6 2,827.1 20 26.9 6.6
Pig 7 2 25.5 507.5 20 26 6.4 9 103.3 2,578.8 25 23.8 6.4
Pig 8 2 30.5 614.5 20 27 6.4 9 113.3 2,755 23.9 27.5 6.2
Pig 9 3 23 463.3 20 27 6.4 11 147.2 2,947.3 20 27.1 6.7
Mean 2.4 28.9 505.7 18.2 23.8 5.6 9.8 132.9 2,670.2 20.3 25.8 6.0
SD 1.1 4.9 4.9 3.5 4.0 1.0 2.6 22.2 485.5 3.9 3.7 1.0
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pathologist examined all histological slides, looking for
any evidence of injury to the renal arteries and the periar-
terial renal connective tissue containing the renal nerves.
Furthermore, slices of renal parenchyma, adrenal glands,
and periarterial connective tissue stroma containing the
ureter, renal vein, and renal lymph nodes were examined
for undesired effects such as thromboemboli, infarcts, and
inflammation.
The NE concentration in the renal parenchyma was
determined to assess the effectiveness of percutaneous
renal sympathicolysis. Immediately after explantation,
both kidneys were homogenized separately in 1.0% for-
mic acid and centrifuged. NE measurement was per-
formed following liquid extraction by high-performance
liquid chromatography (HPLC) according to Bauch
et al. [26]. Details of the method have been described
elsewhere [27].
Blood pressure was measured in all pigs immediately
before the intervention (baseline), directly after the
intervention, and at 4-week follow-up.
Results and discussion
Technical outcome
Image quality was sufficient in all animals and allowed
identification of the renal vessels and possible sonication
spots. In all pigs, the test sonications in the nearby
ipsilateral longissimus muscle led to an increase in
temperature and change in MRI appearance with a focal
increase in T2 signal intensity consistent with edema.
An increase in temperature in the renal perivascular tis-
sue could not be measured reliably due to the surround-
ing fat tissue. The mean duration of the procedure was
90.4 (±20.8) min. For denervation, a mean of 9.8 (±2.6)
sonications with delivery of a mean acoustic energy of
2,670.2 J (±485.5) were applied to the perivascular renal
tissue on the right side.
Safety and efficacy
The procedure was well tolerated by all pigs. Major
complications did not occur. A mild focal skin burn at
the entry spot of the ultrasound beam occurred in three
pigs. The results are summarized in Table 3.
MRI visualization of thermal injury
After the interventions, an increase in signal intensity in
the T2-w MR images due to edema caused by tissue de-
generation was found in the paravertebral muscle adjacent
to the transverse process of the lumbar vertebral body in
all pigs except for the sham-treated pig (Figure 2a,b). A
similar signal increase was found in the perivascular tissue
of three pigs (Figure 2c,d). In nine of the ten treated ani-
mals, temperature maps during the intervention revealed
a significant, almost linear temperature elevation in themuscle around the transverse process and lateral to it. Re-
liable temperature measurement in the target area of the
periarterial tissue was not possible. MRI and MR angiog-
raphy 4 weeks after the intervention showed a normal
right renal artery with no sign of stenosis or other compli-
cations of the surrounding tissues/organs.
Histopathologic assessment
In none of the nine treated pigs did histopathologic ana-
lysis reveal significant signs of neural injury or degener-
ation of the perivascular renal tissue on the treated side.
Only in one pig (pig 4), where MRI showed signal al-
terations, were slight changes consistent with degener-
ation found in perivascular structures (Figure 3).
Norepinephrine measurement
In the first two pigs as well as in five of the seven pigs
with 4-week follow-up, renal NE was lower on the
treated side with the difference ranging from −8.2%
to −27.9% (the calculated difference in pig 7 was −38%).
In two pigs, NE was higher (+10% and +29%) on the
treated side. On average, there was no significant differ-
ence (p = 0.078, paired t test) in NE between the treated
right (391.7 ± 109.5 ng/g) and untreated left (442.2 ±
121.1 ng/g) sides. In pig no. 10, sham treatment was as-
sociated with a significantly lower NE level on the un-
treated side (295.8 vs. 494.4 ng/g) (Table 3).
In one pig (no. 4), treatment led to an NE decrease
of −12% combined with visual changes in MR signal in-
tensity corresponding to edema of the renal perivascular
tissue and the region close to the transverse process.
Moreover, histopathologic analysis revealed signs of de-
generation of sympathetic nerve fibers (Figure 3).
In two pigs, treatment led to MR signal alterations in
the perivascular tissues and a decrease in NE but was
not accompanied by histological changes in the sympa-
thetic nerves. In the remaining pigs, edema was only
found in the tissue surrounding the transverse process.
In this subset, NE levels were variable with some pigs
even showing lower values on the untreated side.
Blood pressure
Pre- and postinterventional systolic and diastolic blood
pressure did not differ significantly with average values
of 124/51 mmHg before the interventions and 124/
54 mmHg at 4-week follow-up. Compared to baseline,
seven of nine pigs showed increased systolic and dia-
stolic blood pressures immediately after the interven-
tions with average values of 140/62 mmHg.
Despite initial success in treating resistant hypertension,
endovascular RFA of renal sympathetic nerves has proced-
ural limitations. Not all patients are candidates for endovas-
cular RFA since there are certain anatomic requirements
to be eligible for the procedure. Furthermore, clinical
Table 3 Overview of results with regard to MR signal intensity, histology, norepinephrine concentrations, and blood pressure
Signal increase in T2-w after intervention Histological
changes
Norepinephrine levelsa Blood pressure
(systolic/diastolic)
No changes Periosseous/transverse
process
Perivascular
tissue
Right Left Change in% Before After 4-week
follow-up
Pig 1 X 285.6 396.2 −27.9 145/46 171/100 X
Pig 2 X 496.3 577.1 −14 119/52 162/83 X
Pig 3 X 478.7 433.1 10 132/74 122/48 93/46
Pig 4 X X X 445.4 509 −12.5 139/84 153/88 135/83
Pig 5 X 317.7 346.1 −8.2 130/42 118/55 118/49
Pig 6 X X 309.1 359.7 −14 145/39 166/33 130/48
Pig 7 X X 267.9 429.5 −38 117/39 144/60 111/34
Pig 8 X 348.9 270.5 29 112/62 152/74 122/52
Pig 9 X 575.8 658.5 −12.6 75/24 123/50 158/66
Pig 10 X 494.4 295.8 67.1 102/54 85/29 123/45
Mean 391.7 442.2 124/51 146/66 124/54
Pigs 1–9 (±109.5) (±121.1)
Mean 402 427.6 122/52 140/62 124/53
Pigs 1–10 (±108.3) (±123.2)
aLLOQ 20 ng/g tissue. Pig nos. 1 and 2 were sacrificed 2 h after the intervention to assess immediate effects on vessels and perivascular tissues. The other eight
pigs were euthanized after 4 weeks. T2 signal intensity increase, histological changes, NE levels of the treated right (italicized) and untreated left kidneys (ng/g) at
4 weeks, and blood pressure values (systolic/diastolic in mmHg) before and after the intervention is given. All treated pigs developed edema in the tissue
adjacent to the transverse process. Edema in the periarterial tissue was found in three pigs and corresponding histological changes in one pig. NE was lower on
the treated side in seven pigs (italicized). Two pigs and the sham-treated pig had higher NE levels on the treated side. Average systolic and diastolic blood
pressure 4 weeks after the intervention did not differ significantly from baseline.
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ranging from 0% to 31% after 1 month and from 0% to
26% after 6 months [28,5,29-32]. Since the recently pub-
lished results of the HTN-3 trial show no significant differ-
ence in blood pressure reduction after 6 months between
patients treated with RFA-based renal denervation and
sham-treated patients [1], it is important to investigate pos-
sible alternative methods for renal denervation.
MRgHiFUS has the potential for noninvasive renal sym-
pathetic nerve ablation because the focused ultrasound
beam can produce a precise focal temperature increase
and thus induce circumscribed tissue degeneration. With
its high intrinsic contrast, MRI can visualize and clearly de-
fine the target area for sympathetic denervation. MRgHi-
FUS is potentially safer for patients, as it is noninvasive
and therefore less susceptible to complications. Further-
more, there are no anatomical restrictions in terms of renal
artery diameter and length.
To our knowledge, this is the first study investigating
the feasibility of MRgHiFUS for renal sympathetic de-
nervation in a porcine model.
As to side effects, there were neither major complica-
tions nor any inadvertent perirenal damage. The mild
focal skin burns seen in three pigs can be explained by
incomplete removal of the pigs’ bristles, leading to insuf-
ficient coupling between the transducer and the skinand therefore a large change in impedance causing local
heating. Since human hair is much thinner and easier to
remove, this should be no matter of concern.
Regarding the efficacy of this technique, the results of
this initial study indicate that renal sympathetic denerv-
ation with MRgFUS in pigs is difficult and leaves much
to be desired in terms of efficacy.
Wang et al. investigated renal denervation with HiFUS
in canines using color Doppler flow imaging (CDFI) for
guidance [33]. In this study, up to six ablations at three
foci of the renal artery led to a significant decrease in
plasma NE concentration and in systolic and diastolic
blood pressure on days 6 and 28 after the interventions
and to degeneration of the targeted nerve fibers.
The lower effectiveness with regard to NE decrease,
changes in MRI signal intensity, and histological changes
in our study is most likely related to an insufficient en-
ergy deposition caused by a small acoustic window with
beam path impediment in the porcine model. In HiFUS,
orthogonal beam orientation to the target region and an
unimpeded beam path are crucial for minimizing energy
reflection and absorption [24]. Bones or fascia within the
acoustic window may distort and partially reflect the
beam and may absorb a large amount of the applied
ultrasound energy. In previous studies investigating the
treatment of uterine fibroids, MR thermometry showed
Figure 2 T2-w FSE images before and after the intervention (pigs 5 and 4). (a, b) T2-w FSE images before and after the intervention (pig 5).
Postinterventional T2-w images show a signal increase within the paravertebral muscle adjacent to the transverse process (blue arrows). No
signal increase is seen in the region of the perivascular tissue (white arrow). (c, d) T2-w FSE images before and after the intervention (pig 4).
Postinterventional T2-w images show a signal intensity increase adjacent to the transverse process (blue arrows) and in the periarterial tissue
(white arrows).
Figure 3 Magnified view of a degenerated sympathetic nerve
fiber (pig 4). Degeneration is indicated by a thickened perineurium
(black arrow) as a correlate of fibrotic remodeling (Elastica van
Gieson stain).
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region (i.e., focal hot spots), which were primarily attrib-
utable to ultrasound beam distortions induced by the
overlying tissue layers [34,35]. These effects can cause
focal hot spots behind the absorbing structures instead
of the target region [24].
In our experiments, MR temperature maps showed a
linear temperature increase in the dorsal perirenal space
(Figure 4) in some pigs. This heating pattern might be
explained by energy absorption of the prominent trans-
verse process and its adjacent fascia. Postinterventional
T2-w images confirmed edema in the tissue adjacent to
the transverse process in most pigs, caused by thermal
injury.
The prominent transverse process in pigs limited the
acoustic window for sonication of the right renal artery.
To maximize the acoustic window, the pigs were placed
in a right oblique position. As a result, however, the
ultrasound beam was suboptimally angulated and had to
partially pass through the right kidney in most pigs,
resulting in a further loss of energy.
Since all test sonications led to heat-induced tissue de-
generation in the longissimus muscle, our results indicate
Figure 4 Real-time temperature map with color-coded
visualization of different tissue temperatures (blue: low
temperature/red: high temperature). The temperature map image
shows focal heating (white arrow) in the dorsal periarterial space,
possibly corresponding to energy absorption at a longish structure
of thickened tissue consistent with an adjacent fascia. The bar
indicated the region of sonciation.
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above, the therapeutic sonication beam was too weak to
induce sufficient thermal ablation of the perivascular
sympathetic fibers.
In our series, pig 5 was treated with the highest acous-
tic power level (166 W) and no thermal effects were
shown. On the other hand, pig 7, which was treated with
the second lowest power level, showed signs of denerv-
ation. This disparity between power level and thera-
peutic effect indicates that the chosen energy levels
might have been sufficient for renal denervation had the
effects of energy absorption not been so substantial.
In humans, the acoustic window is presumed to be lar-
ger due to a greater distance between the kidneys and
the relatively smaller transverse processes. Furthermore,
with increasing distance between the ultrasound trans-
ducer and the target region, the cone-shaped ultrasound
beam is increasingly straightened. A straighter beam in
turn reduces the number of affected tissues, resulting in
fewer reflections.
Precise monitoring of the temperature and temperature
increase in the treated tissue was difficult. PRF thermom-
etry is a method for calculating the applied thermal
dose and determining tissue damage during sonication
using temperature-dependent phase changes in gradient-
recalled echo (GRE) pulse sequences [36-38]. While work-
ing well in fibrous soft tissue or parenchymal soft tissue,
this method is limited in fat as the phase dependence oflipids is almost independent of temperature [39,24]. Since
other techniques of temperature mapping in the periarter-
ial tissue, which consists mainly of fat, were not supported
by our MRgHiFUS device, reliable information on energy
deposition and the resulting tissue degeneration around
the renal artery could not be obtained. A reliable method
of temperature monitoring in fat would help in identifying
insufficient heat development in the target region and en-
able adjustment and optimization of the sonication pa-
rameters during the intervention.
Since all pigs had normal blood pressure values before
the intervention, a drop of systolic and diastolic blood
pressure was not expected. The increase in systolic blood
pressure, observed in six pigs immediately after the inter-
ventions, is likely caused by interventional stress.
This study has some limitations. All pigs were healthy
and normotensive. Results may be different in a hyperten-
sion model. In vivo determination of NE spillover to
characterize sympathetic activity was not available.
Therefore, we measured NE concentration in the renal
parenchyma, which has shown to be a good surrogate par-
ameter in earlier studies [27]. Interestingly, in few pigs,
NE of the treated kidney was higher than that of the non-
treated control. Furthermore, NE values differed between
both kidneys in the sham-treated pig. This finding corre-
sponds to the results of NE measurements in a series
of naive pigs of the same age and species, in which the NE
levels of both kidneys also varied by up to 35% (Ulrich Speck,
unpublished data). With a mean NE level and standard devi-
ation (SD) of 391.7 ± 109.5 to 427.6 ± 123.2, our results are
similar to the values of this ‘control’ group (333.4 ± 50.5 ng/g).
Apart from random variation, potential causes for higher NE
and SD values in the treated kidneys may be attributable to
variations in the time span between euthanasia and kidney
homogenization and storage of the homogenates.
In conclusion, this feasibility study shows that
MRgHiFUS can induce thermal effects to the renal
periarterial sympathetic nerves. Yet, the treatment did
not result in significant renal sympathetic denervation
in a pig model. This is likely due to insufficient periar-
terial energy deposition, which in turn was mainly
attributable to energy absorption by the transverse pro-
cesses and the fascia, which both lie in the beam path.
Since MRgHiFUS treatment in humans is expected to
be easier to perform, due to easier access to the renal
sympathetic nerves, more experimental studies are
needed to further investigate the therapeutic potential
of MRgHiFUS for renal denervation.
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